QA: 2seventy bio Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001860782_2023_2seventy_bio_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 1.8276160454910686, 'aggregate_val': 91496000, 'exp_sum': 32358000, 'exp_to_value': {'remainder_Revenues': 32358000}}

Graph

Absolute values for 0001860782, 2seventy bio Inc.

  xvar xval
0 AssetsCurrent 300,882,000
1 IntangibleAssetsNetIncludingGoodwill 19,358,000
2 PropertyPlantAndEquipmentNet 55,735,000
3 remainder_Assets 280,690,000
4 LiabilitiesCurrent 79,794,000
5 LiabilitiesNoncurrent 266,405,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,726,000
8 SellingGeneralAndAdministrativeExpense 79,450,000
9 ResearchAndDevelopmentExpense 248,735,000
10 remainder_Expenses 24,725,000
11 remainder_Revenues 91,496,000
12 remainder_NetIncome 8,987,000
13 remainder_ComprehensiveNetIncome -2,165,000
  yvar yval
0 Assets 656,665,000
1 Liabilities 346,199,000
2 Expenses 354,636,000
3 Revenues 91,496,000
4 StockholdersEquity 310,466,000
5 NetIncome -254,153,000
6 ComprehensiveNetIncome -255,235,500
7 BaseVar 730,074,000
8 EconomicCapitalRatio 0.556

Edgar->Model Mapping

Feature Distribution

Change over Time